PMN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ProMIS Neurosciences Inc (PMN) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The stock shows overbought technical indicators, weak financial performance, and lacks positive news or catalysts to support a strong buy decision. Additionally, no significant trading trends or influential activity has been observed.
The MACD is positive but contracting, indicating weakening momentum. The RSI is at 82.994, signaling an overbought condition. Moving averages are bullish, but the stock is approaching resistance levels (R1: 25.868). The stock has a 60% chance to decline in the next day (-1.76%) and month (-4.23%), with limited upside potential in the next week (+1.49%).
NULL. No recent news, no AI Stock Picker or SwingMax signals, and no significant trading trends from hedge funds or insiders.
Overbought RSI, weak financial performance in Q3 2025 (Net Income down -224.84% YoY, EPS down -176.91% YoY), and no recent congress trading data or influential activity.
In Q3 2025, the company reported no revenue growth (0% YoY), a significant drop in net income (-224.84% YoY), and a sharp decline in EPS (-176.91% YoY). Gross margin remains at 0%.
No analyst rating or price target data available.
